The battle between Nemetschek’s operating performance and its stock price is turning into a rout for the latter. The Munich-based software group’s shares closed at €56.55 on Friday, shedding another 3.83% and leaving them within striking distance of the 52‑week low of €55.00. Over the past seven sessions the stock has fallen more than 12%, pushing the year‑to‑date decline to nearly 38%. Since touching a 52‑week high of €137.90 last summer, the equity has lost almost 59% of its value.
The trigger for the latest leg down came from across the Atlantic. Oracle, despite posting record revenues and a 47% jump in cloud sales, saw its own shares tumble roughly 10% after the company flagged plans to spend $70 billion in net capital expenditure in 2027, a level that will require heavy debt financing. The market interpreted the message as a warning shot across the entire SaaS sector: rising infrastructure costs could pressure free cash flows and slow the pace of subscription growth. European software stocks quickly followed suit, with SAP, Nemetschek and TeamViewer losing as much as 4.2% as investors repriced the industry’s risk profile.
Yet Nemetschek’s own first‑quarter numbers, released a few weeks ago, tell a fundamentally different story. On a currency‑adjusted basis, revenue expanded 17.0% to €313.1 million, comfortably within the upper end of the company’s full‑year guidance. Reported growth was held back to 10.7% by a weak US dollar, but the underlying subscription and SaaS business surged more than 35%. Earnings per share jumped 34.5% as the recurring model continued to gain traction. Management is targeting up to 15% organic sales growth for the full year 2026, alongside an operating margin of roughly 33%.
The strategic bet that should accelerate this shift is the planned $2.4 billion acquisition of Heavy Construction Systems Specialists (HCSS) from private‑equity firm Thoma Bravo. HCSS provides software for large infrastructure projects such as road and utility construction, a segment where Nemetschek has traditionally been underrepresented. The target generated approximately $215 million in revenue in 2025, with recurring revenue growing 21% and an EBITDA margin of around 40%. Under the deal structure, Nemetschek will hold 72% of the combined segment while Thoma Bravo retains a 28% minority stake. The transaction will add roughly €450 million to net debt, but management expects at least a mid‑double‑digit million‑euro EBITDA synergy benefit by 2028, split evenly between revenue gains and cost savings. Closing is scheduled for the second half of 2026, subject to regulatory clearance.
Should investors sell immediately? Or is it worth buying Nemetschek?
Technical indicators offer little comfort at these levels. The stock is trading about 31% below its 200‑day moving average, and the relative strength index stands at 37.8 – technically oversold but without any clear reversal signal. The 52‑week low at €55.00 is now only 2.8% away. If that support fails, further algorithmic selling pressure could accelerate the decline.
The chasm between market pricing and analyst expectations has rarely been wider. The consensus price target sits at €94, implying upside of almost 70% from the current quote. The forward price‑to‑earnings multiple for 2026 estimates has compressed to 26, historically a low level for Nemetschek. Meanwhile, the company is showcasing new AI‑powered solutions at the AIA26 architecture trade fair in San Diego, where brands such as Bluebeam, Graphisoft and Vectorworks are being woven together under the “Connected Intelligence” banner.
The next major fundamental catalyst arrives in July, when Nemetschek releases its first‑half figures. A reaffirmation of double‑digit organic growth, combined with concrete progress toward the HCSS closing, could force investors to square the disconnect between operational strength and share price. But until the sector’s fears over SaaS cash flows subside, the stock’s journey back to fundamental reality remains a steep uphill climb.
Ad
Nemetschek Stock: Buy or Sell?! New Nemetschek Analysis from June 12 delivers the answer:
The latest Nemetschek figures speak for themselves: Urgent action needed for Nemetschek investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 12.
Nemetschek: Buy or sell? Read more here...









